STOCKWATCH
·
Biotechnology: Biological Products (No Diagnostic Substances)
InvestmentApr 28, 2026, 05:02 PM

SCLX to Invest $120M in Datavault AI for Quantum Network & Revenue Share

AI Summary

Scilex Holding Co. entered a binding term sheet with Datavault AI Inc. for a proposed cash contribution and revenue participation arrangement. Scilex will provide an upfront cash contribution of $120,000,000 to fund Datavault's deployment of quantum-ready GPU infrastructure across 100 US cities. In return, Datavault will pay Scilex a percentage of gross revenues from this network, starting at 30% until $250 million, then 15% until $1.2 billion, and 5% thereafter. The agreement includes customary provisions, but there is no assurance that the definitive agreement will be entered into or that the transaction will be consummated.

Key Highlights

  • SCLX entered a binding term sheet with Datavault AI Inc. for a cash contribution and revenue participation arrangement.
  • SCLX will make an upfront cash contribution of $120,000,000 to Datavault.
  • The payment will fund Datavault's quantum-ready GPU infrastructure deployment across 100 US cities.
  • Datavault will pay SCLX 30% of Network Revenues until $250,000,000 is reached.
  • Payments then shift to 15% of Network Revenues until a total of $1,200,000,000 is reached.
  • After the $1.2B cap, SCLX will receive 5% of Network Revenues for the GPUs' lifetime.
  • The final closing of the upfront payment is expected by December 31, 2026.
SCLX
Biotechnology: Biological Products (No Diagnostic Substances)
Scilex Holding Co

Price Impact